John Chester
Impact in
Papers in
- Co-authors
- Sarah E. Jackson (1 shared paper)Richard G. Vile (16 shared papers)Kevin J. Harrington (15 shared papers)Alan Melcher (11 shared papers)Rosa María Díaz (11 shared papers)Jill Thompson (11 shared papers)Peter J. Selby (16 shared papers)Timothy Kottke (8 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Gene Therapy (4 papers)Oncotarget (4 papers)British Journal of Cancer (4 papers)Molecular Therapy (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
John Chester
81 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 123
- Oncology 1.0k
- Genetics 957
- Biotechnology 223
- Molecular Biology 1.1k
- Immunology 285
Countries citing papers authored by John Chester
This map shows the geographic impact of John Chester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Chester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Chester more than expected).
Fields of papers citing papers by John Chester
This network shows the impact of papers produced by John Chester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Chester. The network helps show where John Chester may publish in the future.
Co-authors
The 25 scholars most cited alongside John Chester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 261 | |
| 2 | 2012 | 154 | |
| 3 | 2010 | 147 | |
| 4 | 2017 | 143 | |
| 5 | 2005 | 121 | |
| 6 | 2007 | 117 | |
| 7 | 2002 | 111 | |
| 8 | 2014 | 95 | |
| 9 | 2009 | 92 | |
| 10 | 2013 | 86 | |
| 11 | 1989 | 83 | |
| 12 | 2010 | 78 | |
| 13 | 2008 | 76 | |
| 14 | 2011 | 73 | |
| 15 | 2010 | 68 | |
| 16 | 2018 | 55 | |
| 17 | 2008 | 46 | |
| 18 | 2008 | 40 | |
| 19 | 1985 | 39 | |
| 20 | 2018 | 39 |
About John Chester
John Chester is a scholar working on Genetics, Oncology, Molecular Biology, Surgery and Biotechnology, having authored 83 papers that have together received 2.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (29 papers), CAR-T cell therapy research (18 papers), Bladder and Urothelial Cancer Treatments (15 papers), Viral Infectious Diseases and Gene Expression in Insects (11 papers), Cancer Research and Treatments (11 papers), RNA Interference and Gene Delivery (7 papers), Testicular diseases and treatments (5 papers) and Multiple and Secondary Primary Cancers (4 papers). The work is most often cited by research in Oncology (1.0k citations), Genetics (957 citations), Biotechnology (223 citations), Molecular Biology (1.1k citations) and Immunology (285 citations). John Chester has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sarah E. Jackson, Richard G. Vile, Kevin J. Harrington, Alan Melcher, Rosa María Díaz, Jill Thompson, Peter J. Selby, Timothy Kottke, Margaret A. Knowles and Jian Qiao. Their work appears in journals such as Journal of Clinical Oncology, Gene Therapy, Oncotarget, British Journal of Cancer and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.